BLIS TechnologiesNZSE:BLT +6.25% Days Inventory is 180.19 as of Mar. 2026, which is 74% above its 10-year median of 103.32. The stock has 4 warning signs investors should review. Among 638 Biotechnology companies, BLIS Technologies ranks better than 64.42% on this metric.
The historical rank and industry rank for BLIS Technologies's Days Inventory or its related term are showing as below:
NZSE:BLT'
s Days Inventory Range Over the Past 10 Years
Min: 56.53 Med: 103.32 Max: 169.32
Current: 124.64
During the past 13 years, BLIS Technologies's highest Days Inventory was 169.32. The lowest was 56.53. And the median was 103.32.
NZSE:BLT's Days Inventory is ranked better than 64.42% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs NZSE:BLT: 124.64
BLIS Technologies's Days Inventory
increased
from Mar. 2025 (101.84) to Mar. 2026 (180.19).
It might indicate that BLIS Technologies's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
BLIS Technologies's Inventory Turnover for the
six
months ended in Mar. 2026 was 1.01.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BLIS Technologies's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.28.
BLIS Technologies (NZSE:BLT) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BLIS Technologies's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BLIS Technologies's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
BLIS Technologies Days Inventory Related Terms
BLIS Technologies Days Inventory Historical Data
* Premium members only.
The historical data trend for BLIS Technologies's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:BLT vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, BLIS Technologies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BLIS Technologies Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BLIS Technologies's Days Inventory distribution charts can be found below:
* The bar in red indicates where BLIS Technologies's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BLIS Technologies (NZSE:BLT) has a Days Inventory of 180.19 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BLIS Technologies and its competitors. This is 74% above median its historical median of 103.32. Over the past decade, BLIS Technologies' Days Inventory has ranged from 56.53 to 169.32. According to the industry distribution chart, BLIS Technologies ranks #227 out of 638 companies in the Biotechnology industry, placing it in the top 35.6%.
Is BLIS Technologies' Days Inventory too high?
BLIS Technologies' current Days Inventory of 180.19 is 74% above median its 10-year median of 103.32. Over the past 10 years, this metric has ranged from a low of 56.53 to a high of 169.32. The Biotechnology industry median Days Inventory is 183.20. BLIS Technologies' value of 180.19 is 1.6% below this industry median. Based on the distribution chart, BLIS Technologies ranks #227 out of 638 companies in the Biotechnology industry, which is above the industry midpoint.
How does BLIS Technologies' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BLIS Technologies ranks #227 out of 638 companies for Days Inventory. This puts BLIS Technologies in the upper half of its industry. The industry median Days Inventory is 183.20. BLIS Technologies' value of 180.19 is 1.6% below this benchmark. Historically, BLIS Technologies' own Days Inventory has ranged from 56.53 to 169.32 over the past decade. While the company's 10-year median is 103.32 vs. the industry median of 183.20, BLIS Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BLIS Technologies's current Days Inventory of 180.19 is 1.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BLIS Technologies and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BLIS Technologies's current Days Inventory is 180.19, which is 74% above median its own 10-year median of 103.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BLIS Technologies stock overvalued right now?
Based on GuruFocus' analysis, BLIS Technologies (NZSE:BLT) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$0.02, compared to a current price of NZ$0.02 — trading 15% below its estimated fair value. The current Days Inventory is 180.19, which is 74% above median its 10-year median of 103.32 and 1.6% below the Biotechnology industry median of 183.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For BLIS Technologies (NZSE:BLT), the current Days Inventory is 180.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18, which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from North America. The company also generates a small portion of revenue from Non-core business, which includes grants and interest revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:BLT has been successfully added to your 